Galactosidase, alpha (GLA) ELISA Kits

GLA encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. Additionally we are shipping GLA Antibodies (127) and GLA Proteins (18) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
GLA 2717 P06280
GLA 11605  
Anti-Rat GLA GLA 363494  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top GLA ELISA Kits at antibodies-online.com

Showing 10 out of 38 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human 1.95 pg/mL 7.8-500 pg/mL Typical standard curve 96 Tests Log in to see 13 to 16 Days
$1,026.67
Details
Mouse 7.81   96 Tests Log in to see 15 to 18 Days
$910.56
Details
Pig 46.875 pg/mL 78.125-5000 pg/mL   96 Tests Log in to see 12 to 14 Days
$715.00
Details
Chicken 2.344 pg/mL 3.906-250 pg/mL   96 Tests Log in to see 12 to 14 Days
$715.00
Details
Rabbit 1.875 pg/mL 3.125-200 pg/mL   96 Tests Log in to see 12 to 14 Days
$715.00
Details
Guinea Pig
  96 Tests Log in to see 15 to 18 Days
$707.14
Details
Sheep
  96 Tests Log in to see 15 to 18 Days
$707.14
Details
Cow
  96 Tests Log in to see 15 to 18 Days
$707.14
Details
Dog
  96 Tests Log in to see 15 to 18 Days
$707.14
Details
Monkey
  96 Tests Log in to see 15 to 18 Days
$707.14
Details

More ELISA Kits for GLA Interaction Partners

Human Galactosidase, alpha (GLA) interaction partners

  1. we presented the clinical characters of a Chinese FD pedigree mimicking familial episodic pain. Furthermore, our finding suggests that a novel double mutation of GLA (c.273_276del TGAT in cis with c.281G>T) is associated with FD

  2. Results showed that most Fabry disease patients carrying GLA (show NAT8 ELISA Kits) IVS4+919A did not show abnormal cardiac phenotypes. The near-absence of GLA (show NAT8 ELISA Kits) IVS4+919A in heart disease cohort suggested that this variant is not a frequent cause of overt heart diseases in Taiwan.

  3. Enzyme activities (acid alpha-glucosidase (GAA), galactocerebrosidase (GALC (show GALC ELISA Kits)), glucocerebrosidase (GBA (show GBA ELISA Kits)), alpha-galactosidase A (GLA), alpha-iduronidase (IDUA (show IDUA ELISA Kits)) and sphingomyeline phosphodiesterase-1 (SMPD-1 (show SMPD1 ELISA Kits))) were measured on ~43,000 de-identified dried blood spot (DBS (show MCF2L ELISA Kits)) punches, and screen positive samples were submitted for DNA sequencing to obtain genotype confirmation of disease risk

  4. This longitudinal Fabry Registry study analyzed data from patients with Fabry disease to determine the incidence and type of severe clinical events following initiation of enzyme replacement therapy (ERT) with agalsidase beta, as well as risk factors associated with occurrence of these events

  5. alpha-galactosidase A mutation, IVS4-type Fabry disease has features similar to those of classic Fabry disease and a higher frequency of deep white matter hyperintensities and a higher incidence of infarctions and pulvinar signs than in healthy controls

  6. We demonstrate that the wild-type sequence harbors an hnRNP A1 (show HNRNPA1 ELISA Kits) and hnRNP A2/B1 (show HNRNPA2B1 ELISA Kits)-binding exonic splicing silencer (ESS) overlapping the 5'splice site (5'ss) that prevents pseudoexon inclusion.we demonstrate that splice switching oligonucleotide (SSO) mediated blocking of the pseudoexon 3'ss and 5'ss effectively restores normal GLA (show NAT8 ELISA Kits) splicing

  7. Four patients had non-amenable mutant forms of a-Gal (show GAL ELISA Kits) based on the validated cell-based assay conducted after treatment initiation and were excluded from primary efficacy analyses only.

  8. Mesenchymal stem cells with reduced GLA (show NAT8 ELISA Kits) activity are prone to apoptosis and senescence due to impaired autophagy and DNA repair capacity.

  9. we review the various types of GLA (show NAT8 ELISA Kits) variants and recommend that pathogenicity be considered only when associated with elevated globotriaosylceramide in disease-relevant organs and tissues as analyzed by mass spectrometry.

  10. findings revealed the alternative splicing mechanism of GLA (show NAT8 ELISA Kits) (IVS4+919G>A), and a potential treatment for this specific genetic type of Fabry disease by amiloride in the future

Mouse (Murine) Galactosidase, alpha (GLA) interaction partners

  1. Therefore, we confirmed the associations among Golgi function, fibrosis, and autophagy. Moreover, GOLGA2 knockout mice may be a potentially valuable animal model for studying autophagy-induced fibrosis.

  2. the GM130-deficient mouse provides a valuable model for investigating the etiology of human globozoospermia.

  3. Mice with alpha-galactosidase A deficiency show age-dependent and distinct deficits of the sensory system.

  4. In oocyte meiosis, GM130 localization and expression patterns are regulated by FMNL1 (show FMNL1 ELISA Kits).

  5. The histological changes in Gla KO mice better resemble the type 2 later-onset phenotype observed in patients with residual alpha-galactosidase A activity.

  6. our findings imply that the alpha-GalA KO mouse is a good model in which to study the peripheral small fiber neuropathy exhibited by FD patients

  7. we demonstrate an age-dependent microvasculopathy of the mesenteric artery in a murine model of Fabry disease (galactosidase A-knockout mice) resulting from dysregulation of the vascular homeostatic enzyme endothelial nitric oxide synthase (eNOS (show NOS3 ELISA Kits))

  8. GM130 regulates microtubule organization and might cooperate with the MAPK (show MAPK1 ELISA Kits) pathway to play roles in spindle organization, migration and asymmetric division during mouse oocyte maturation

  9. It suggested that there could be a combination of GLA deficiency and FVL (show F5 ELISA Kits) or other thrombosis-related gene defect in patients with genetic severe early-onset thrombosis.

  10. present Toll (show TLR4 ELISA Kits)-like receptor-dependent negative regulation of alpha-Gal-A as a mechanistic link between pathogen recognition and self lipid antigen induction for natural killer T cells

GLA Antigen Profile

Antigen Summary

This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.

Gene names and symbols associated with Galactosidase, alpha (GLA) ELISA Kits

  • galactosidase alpha (GLA) antibody
  • galactosidase, alpha (Gla) antibody
  • galactosidase, alpha (gla) antibody
  • galactosidase alpha S homeolog (gla.S) antibody
  • galactosidase alpha (gla) antibody
  • alpha-galactosidase (agaN) antibody
  • aga (aga) antibody
  • alpha-galactosidase (agaL) antibody
  • alpha-galactosidase (SCO0541) antibody
  • alpha-galactosidase (rafA) antibody
  • alpha-galactosidase (melA) antibody
  • alpha-galactosidase (galA) antibody
  • alpha-galactosidase A (ANI_1_2528074) antibody
  • alpha-galactosidase A (ANI_1_1502124) antibody
  • alpha-galactosidase A (AOR_1_390174) antibody
  • alpha-galactosidase A (CpipJ_CPIJ002066) antibody
  • alpha-galactosidase (aga) antibody
  • alpha-galactosidase A (MCYG_00962) antibody
  • alpha-galactosidase A (MCYG_00791) antibody
  • alpha-galactosidase (gla) antibody
  • alpha-galactosidase A (Tsp_02909) antibody
  • alpha-galactosidase A (Tsp_02508) antibody
  • golgi autoantigen, golgin subfamily a, 2 (Golga2) antibody
  • galactosidase alpha (Gla) antibody
  • galactosidase, alpha (GLA) antibody
  • Ags antibody
  • alpha-GAL antibody
  • AO090005000217 antibody
  • AW555139 antibody
  • GALA antibody
  • GM130 antibody
  • MGC130872 antibody
  • mKIAA4150 antibody
  • SCF11.21 antibody
  • SMU.877 antibody
  • zgc:101584 antibody

Protein level used designations for Galactosidase, alpha (GLA) ELISA Kits

agalsidase alfa , alpha-D-galactosidase A , alpha-D-galactoside galactohydrolase 1 , alpha-gal A , alpha-galactosidase A , melibiase , alpha-D-galactoside galactohydrolase , Alpha-galactosidase A , galactosidase, alpha , alpha-galactosidase A-like , alpha-galactosidase , Alpha-galactosidase , 130 kDa cis-Golgi matrix protein , Golgin subfamily A member 2 , SY11 protein , golgin-95

GENE ID SPECIES
2717 Homo sapiens
11605 Mus musculus
363494 Rattus norvegicus
422188 Gallus gallus
450083 Danio rerio
465761 Pan troglodytes
480988 Canis lupus familiaris
532742 Bos taurus
703129 Macaca mulatta
734749 Xenopus laevis
100022779 Monodelphis domestica
100060370 Equus caballus
100145767 Xenopus (Silurana) tropicalis
100344610 Oryctolagus cuniculus
100409841 Callithrix jacchus
100480888 Ailuropoda melanoleuca
100595113 Nomascus leucogenys
988766 Clostridium perfringens str. 13
1021683 Bifidobacterium longum NCC2705
1028243 Streptococcus mutans UA159
1095964 Streptomyces coelicolor A3(2)
1174420 Yersinia pestis CO92
1255824 Salmonella enterica subsp. enterica serovar Typhimurium str. LT2
2956399 Yersinia pseudotuberculosis IP 32953
3977399 Lactobacillus salivarius UCC118
4983447 Aspergillus niger CBS 513.88
4987403 Aspergillus niger CBS 513.88
5989256 Aspergillus oryzae RIB40
6032795 Culex quinquefasciatus
7264928 Bifidobacterium animalis subsp. lactis AD011
9223595 Arthroderma otae CBS 113480
9226616 Arthroderma otae CBS 113480
9450395 Brachyspira pilosicoli 95/1000
10899858 Trichinella spiralis
10903123 Trichinella spiralis
99412 Mus musculus
100718405 Cavia porcellus
407057 Sus scrofa
Selected quality suppliers for GLA (GLA) ELISA Kits
Did you look for something else?